MedTrace Logo

Treatment and Prevention of Severe Anemia in Pregnant Zanzibari Women

NCT00148629 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 2500

Last updated 2026-02-13

No results posted yet for this study

Summary

The purpose of this research is to compare the efficacy of two low-cost low intervention packages to prevent and treat severe anemia in pregnant women in Zanzibar, Tanzania. The two packages are Standard of Care as described by the WHO (presumptive treatment for malaria and helminths plus daily iron + folic acid supplements) and Enhanced Care (Standard of Care plus daily multivitamins and a 2nd dose of anthelminthic.)

Conditions

Interventions

DRUG

multivitamin, mebendazole

Sponsors & Collaborators

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • UNICEF

    collaborator OTHER

  • Johns Hopkins Bloomberg School of Public Health

    collaborator OTHER

  • Cornell University

    lead OTHER

Principal Investigators

  • Rebecca J Stoltzfus, PhD · Cornell University

  • James M Tielsch, PhD · The Johns Hopkins Bloomberg School of Public Health

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-04-30
Primary Completion
2008-01-31
Completion
2008-01-31

Countries

  • Tanzania

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00148629 on ClinicalTrials.gov